Literature DB >> 12188392

Screening for microalbuminuria in type 2 diabetes: a reconsideration.

Supamai Soonthornpun1, Rattana Leelawattana, Atchara Thamprasit, Chatchalit Rattarasarn, Worawong Setasuban, Natawan Thammakumpee.   

Abstract

To study the effect of timing of urine collection in determination of microalbuminuria in type 2 diabetic patients, timed urine (night time and daytime) as well as spot urine (first morning and random morning) samples were collected from 44 type 2 diabetic patients, 21 with normoalbuminuria and 23 with microalbuminuria. The methods of spot urine albumin expression for microalbuminuria were also compared between albumin concentration (AC) and albumin to creatinine ratio (ACR). Night time albumin excretion rate (AER) was 16 per cent lower and daytime AER was 13 per cent higher than 24-h AER (p<0.001). Forty-one (93%) of both night time and daytime urine samples had results corresponding with 24-h AER. For the spot urine, expression as AC showed a slightly stronger correlation with 24-h AER than expression as ACR. The levels of albumin in random morning urine samples were 50 and 35 per cent significantly higher than those in first morning urine samples when expressed as AC and ACR, respectively. In conclusion, because of low diurnal variation of AER, either daytime or night time urine could be used for screening of microalbuminuria in type 2 diabetes. Since mean albumin levels obtained from random morning urine were higher than those obtained from first morning urine, the cut-off level should be set higher in random morning urine in order to give comparable sensitivity in predicting microalbuminuria. The spot urine, either first morning or random morning urine, had a good correlation with the 24-h AER whether expressed as AC or ACR. Given the cost of the latter, the authors suggested measuring spot urine AC instead of ACR for screening of microalbuminuria in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12188392

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  -to: Wu AYT, Kong NCT, de Leon FA, Pan CY, Tai TY, Yeung VTF, Yoo SJ, Rouillon A, Weir MR, for the MAPS investigators (2005) An alarming high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48: 17-26.

Authors:  C Rattarasarn
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

2.  Spot urinary microalbumin concentration, metabolic syndrome and type 2 diabetes: Tehran lipid and glucose study.

Authors:  Zahra Gaeini; Zahra Bahadoran; Parvin Mirmiran; Reza Norouzirad; Asghar Ghasemi; Fereidoun Azizi
Journal:  BMC Endocr Disord       Date:  2022-03-08       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.